IPO Boutique

Parabilis Medicines, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Parabilis Medicines, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Parabilis Medicines, Inc.PBLS -
NASDAQ
$17.00-$19.00 $20.00 $33.3533.5 million6/10/2026
Leerink Partners, BofA Securities, Evercore ISI, Guggenheim Securities, LifeSci Capital
Co-Manager(s):
Health Care
Filing(s):

Filed 2026-05-19
Terms Added 2026-06-04



Parabilis Medicines, Inc. Quote & Chart - Click for current quote - PBLS

About Parabilis Medicines, Inc. (adapted from Parabilis Medicines, Inc. prospectus):
They are a clinical-stage biopharmaceutical company built to develop transformative medicines addressing some of the most consequential, yet historically undruggable, protein targets driving human disease.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "PBLS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2026 IPO Boutique. All Rights Reserved